- Home
- SSRM vs MIRM Comparison
SSRM vs MIRM Comparison
Compare SSRM & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSRM
- MIRM
- Stock Information
- Founded
- SSRM 1946
- MIRM 2018
- Country
- SSRM United States
- MIRM United States
- Employees
- SSRM N/A
- MIRM N/A
- Industry
- SSRM Precious Metals
- MIRM Biotechnology: Pharmaceutical Preparations
- Sector
- SSRM Industrials
- MIRM Health Care
- Exchange
- SSRM Nasdaq
- MIRM Nasdaq
- Market Cap
- SSRM 2.2B
- MIRM 2.5B
- IPO Year
- SSRM 1996
- MIRM 2019
- Fundamental
- Price
- SSRM $13.16
- MIRM $49.09
- Analyst Decision
- SSRM Hold
- MIRM Strong Buy
- Analyst Count
- SSRM 3
- MIRM 9
- Target Price
- SSRM $10.53
- MIRM $66.22
- AVG Volume (30 Days)
- SSRM 3.3M
- MIRM 449.1K
- Earning Date
- SSRM 07-30-2025
- MIRM 08-06-2025
- Dividend Yield
- SSRM N/A
- MIRM N/A
- EPS Growth
- SSRM N/A
- MIRM N/A
- EPS
- SSRM 0.42
- MIRM N/A
- Revenue
- SSRM $1,082,002,000.00
- MIRM $379,251,000.00
- Revenue This Year
- SSRM $40.21
- MIRM $35.83
- Revenue Next Year
- SSRM $19.05
- MIRM $16.83
- P/E Ratio
- SSRM $30.53
- MIRM N/A
- Revenue Growth
- SSRM N/A
- MIRM 69.31
- 52 Week Low
- SSRM $4.32
- MIRM $33.45
- 52 Week High
- SSRM $13.46
- MIRM $54.23
- Technical
- Relative Strength Index (RSI)
- SSRM 61.30
- MIRM 53.95
- Support Level
- SSRM $12.04
- MIRM $49.39
- Resistance Level
- SSRM $12.67
- MIRM $51.93
- Average True Range (ATR)
- SSRM 0.48
- MIRM 1.53
- MACD
- SSRM -0.05
- MIRM -0.27
- Stochastic Oscillator
- SSRM 78.87
- MIRM 31.40
About SSRM SSR Mining Inc.
SSR Mining Inc is a minerals company focused on mining precious metals in the Americas. More than half of Silver Standard's revenue is attributable to the production of gold, with a key portion derived from silver production. The company owns and operates the Marigold mine in Nevada, United States; the Seabee Gold Operation in Saskatchewan, Canada; and the Puna mine in Argentina. The majority of gold production is derived from the Marigold mine, and Silver Standard's silver production is principally derived from the Puna mine.
About MIRM Mirum Pharmaceuticals Inc.
Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.